Checkpoint: How to Read a Cognitive Supplement Result

The evidence for creatine monohydrate and cognition is easiest to misunderstand when each part is treated as a self-sufficient fact. A plausible brain-energy mechanism, a difference on a memory or speed task, a pooled effect size, and a practical claim are connected, but they are not the same statement. This checkpoint joins those pieces into one reading method so that a positive headline can be examined for endpoint, magnitude, certainty, independence, and applicability.

A result is a chain, not a single fact

Start with the mechanism. Creatine participates in a phosphocreatine system that can help regenerate ATP, giving researchers a reason to investigate energy-demanding neural work. That rationale points toward a testable question: do adults receiving creatine monohydrate perform differently from a control group on a defined cognitive task? It does not point directly to the conclusion that creatine improves intelligence, learning, judgment, or everyday productivity.

The next link is the endpoint. The 2024 review did not measure one thing called “brain performance.” It examined memory, attention, executive function, processing speed, and overall cognition, using scores and completion times. These outcomes overlap, but they are not interchangeable. A memory result speaks most directly to the memory measures that entered the analysis. A faster attention-time result speaks to the time required for selected tasks. Neither result automatically represents every aspect of attention or memory.

The third link is the estimate. A standardized mean difference expresses the separation between creatine and control groups on a common scale, while the confidence interval shows how uncertain that estimate is under the analysis model. The review reported a memory estimate around 0.3 standard deviations, a smaller negative estimate for attention time, and a larger negative estimate for processing-speed time. The negative signs have a directional meaning: for time-based outcomes, they represent less time to complete the task. They do not mean that the intervention made cognition “negative.”

The fourth link is the practical interpretation. A result can be statistically distinguishable from zero and still be narrow in what it says. It may describe a laboratory task without showing a meaningful change in daily function. It may be based on mostly healthy adults while being discussed as though it applies to older adults or people with neurological disease. It may be a pooled result whose precision depends on how multiple outcomes were counted. The claim becomes broader at every step, and each broadening requires additional evidence.

The claim ladder looks like this:

flowchart LR A["Biological plausibility"] --> B["Defined laboratory endpoint"] B --> C["Pooled effect estimate"] C --> D["Certainty and independence check"] D --> E["Conditional practical claim"] D --> F["Unsupported universal claim"]

This is why “creatine improves cognition” is too compressed to evaluate. It leaves out the mechanism’s role, the exact task, the comparison, the estimate’s uncertainty, and the population.